CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- SC 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D/A Stake Beneficial Ownership Report
- 6-K/A Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 21 of 29 · 564 filings